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多巴胺 D2 受体（Dopamine D2 receptors, D2R）在调控眼球的屈光发育中
发挥重要作用，但其具体的作用机制尚不清楚。我们考虑 DA/D2R可能是通过
调控下游的信号通路来发挥作用。在本论文中，我们用小鼠形觉剥夺近视

















































Myopia is a common refractive error that can cause a variety of serious complications 
and blindness. It is important to find the mechanism of myopia development. 
Although numerous risk factors have been studied over decades of epidemiological 
and experimental research, a comprehensive mechanistic framework for refractive 
error development in humans remains elusive. It is necessary to take further study to 
understand the pathogenesis of myopia. 
Dopamine(DA) and  dopamine receptor 2 (D2R) play important roles in the 
regulation of eye refractive development. But the exact mechanism is largely 
unknown. In our study, we found that  Wnt/β-catenin signal pathway was changed in 
the retina of form deprivation myopia(FDM) mice, which regulated by the DA/D2R 
signal pathway. FDM mice treated with D2R agonist quinpirole can enhance the 
development of myopia with more activation of  Wnt/β-catenin pathway, whereas 
FDM mice treate with D2R antagonist sulpiride inhibit myopia with less activation of  
Wnt/β-catenin pathway. To evaluate the activation status of the canonical Wnt/β-
catenin pathway in the retina of myopia mice, we have measured retinal levels of total 
β-catenin after FDM treatment 1, 3, 5,7,14 and 28 days and found that Wnt/β-catenin 
signal pathway was activated in the early stage of FDM. We also observed a greater 
myopic shift, increased vitreous chamber depth and rearrangement scleral collagen 
fibril in APC
Min
 mice, in which  Wnt /β-catenin signaling pathway was activated. 
Meanwhile, an inhibition of  Wnt /β-catenin signaling pathway with niclosamide 
administration  can attenuate the development of myopia in the FDM mice and 
APC
Min
 mice. Moreover, we also demonstrated that DKK1, Wnt/β-catenin signaling 
pathway secreted inhibitor, was significantly lower in the serum of high myopia 
patients compared with healthy control group and moderate myopia group. It is 















myopia in clinical.  
In summary, our findings provide evidence that the canonical Wnt/β-catenin 
signal pathway regulated by DA/D2R plays an important role in the postnatal 
refractive development  
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近视患者中， 近视度数高于-5.00D者占 20%，约占总统计人群的 7%。Curtni
报道美国近视患者中，近视度数高于-6.00D者占 27%到 32%，约占人群的 0.5-
2.5%。林 6大范围调查台湾青少年近视发病率，发现 1983年台湾学童 7岁，12
岁，15岁和 18岁近视患病率分别为 5.8%， 36.7% ， 64.2%和 74%；而 2000年
分别为 21%，61%，81%和 84%。此外，高度近视的患病率（>-6 D）在 18岁













   
图 1.1 高度近视患者眼底病变 
A，后巩膜葡萄肿；B，视网膜裂孔；C，脉络膜新生血管；D，黄斑萎缩。 
Fig 1.1 Characteristic pathological changes in the high myopia patients. 
A, posterior scleral staphyloma. B, retina split holes. C, Choroidal neovascular 



































差， 形觉剥夺等诱导因素常难以维护， 如需要订制特别的头套并在头套上加镜  
 
图 1.2 研究近视的主要动物模型。 
小鸡；B，豚鼠；C，小鼠；D，恒河猴。 
Fig.1.2  Animal model of myopia. 
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